Sanj K Patel Net Worth & Insider Trades
Sanj K Patel - Chairman & CEO, Kiniksa Pharmaceuticals, Ltd
What is Sanj K Patel's Net Worth?
The current estimated net worth of Kiniksa Pharmaceuticals, Ltd's Chairman & CEO, Sanj K Patel, is estimated to be about $9.72M . Sanj K Patel owns about 193,131 units of Kiniksa Pharmaceuticals, Ltd common stock. In the last 4 years at Kiniksa Pharmaceuticals, Ltd, Sanj K Patel has sold an estimated value of $7.26M worth.
What is Sanj K Patel's Past Insider Trading?
Sanj K Patel's largest purchase order was 151,572 units , worth over $241K on October 14, 2020. Sanj K Patel's largest sale order was 251,572 units , worth over $5.29M on October 14, 2020. In total, Sanj K Patel has made about 12 transactions over 4 years of their time at Kiniksa Pharmaceuticals, Ltd. Sanj K Patel usually trades in March, with the busiest year in 2020 and 2021. The most recent transaction was a sale order of 56,159 units , worth over $1.29M on February 10, 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sanj Patel
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Sanj K Patel's Salary in 2020?
As Chairman & CEO of Kiniksa Pharmaceuticals, Ltd, Sanj K Patel has a total base salary of $780,000 . Sanj K Patel received compensation valued at about $5,313,564 in 2020 after becoming Chairman & CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $633,750 , option awards of $3,888,414 , other earnings, plans or compensations of $633,750 , and other compensation of $11,400 .
What is Sanj K Patel's' Mailing Address?
- Mailing address is C/o Kiniksa Pharmaceuticals, Ltd. Clarendon House, 2 Church Street Hamilton D0 HM11 Bermuda
Kiniksa Pharmaceuticals, Ltd Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sanj K. Patel | 2020 | $780,000 | $633,750 | $3,888,414 | $633,750 | $11,400 | $5,313,564 |
| Sanj K. Patel | 2019 | $780,000 | $456,300 | $3,518,171 | $456,300 | $11,200 | $4,765,671 |
| Thomas Beetham | 2020 | $440,000 | $220,000 | $1,620,173 | $220,000 | $11,400 | $2,291,573 |
| Qasim Rizvi, MBChB., MBA | 2020 | $431,970 | $188,987 | $1,620,173 | $188,987 | $11,400 | $2,252,530 |
| Qasim Rizvi, MBChB., MBA | 2019 | $392,700 | $123,701 | $880,884 | $123,701 | $11,200 | $1,503,573 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1730430/000110465921056540/tm212498-1_def14a.htm
What are Kiniksa Pharmaceuticals, Ltd's Past Insider Trades?
Kiniksa Pharmaceuticals, Ltd's most recent insider trade came on September 6, 2023 by John Paolini who sold 1,641 units worth $29.05K . In the last 5 years, insiders at Kiniksa Pharmaceuticals, Ltd have sold an estimated value of $12.26M and bought an estimated value of $72.04M worth of shares. Insider trading is most common in March, with the busiest year in 2023. The most active traders at the company are John Paolini, CHIEF MEDICAL OFFICER, Sanj Patel, CHAIRMAN & CEO, and Mark Ragosa, CHIEF FINANCIAL OFFICER .
Kiniksa Pharmaceuticals, Ltd. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||